Glazer Capital’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
Other funds holding NAUT
Glazer Capital's NAUT Position: Q1 2021 in Review
Glazer Capital sold out of Nautilus Biotechnolgy (NAUT) in Q1 2021, closing a stake of 320,017 shares — an estimated $3.47M sold.
Glazer Capital first reported a position in NAUT in Q3 2020 and held it in 2 quarters. The position peaked at $3.62M in Q3 2020. 44 funds tracked by Wall St. Rank hold NAUT as of Q1 2021.
- Glazer Capital reported no remaining Nautilus Biotechnolgy position as of Q1 2021 after selling out during the quarter.
- Glazer Capital sold 320,017 Nautilus Biotechnolgy shares in Q1 2021, an estimated $3.47M.
- Glazer Capital first reported a position in Nautilus Biotechnolgy in Q3 2020 and held it in 2 quarters.
- Glazer Capital's Nautilus Biotechnolgy position peaked at $3.62M in Q3 2020.
- 44 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2021.
Based on Glazer Capital's 13F filing for Q1 2021, filed 14 May 2021.